Neuronetics Inc
STIMHealthcare·Medical Devices·USA·Micro·NASD·Nov 13 • 5:10 AM ET
1.47+0.04 (2.80%)
2026-11-13 13:22 CET
Market cap
$114.28M
Revenue, TTM
159.76 USD m
Net income, TTM
-23.08 USD m
Free cash flow, TTM
-9.58 USD m
EPS diluted, TTM
-0.33
Price
STIM against its 20, 50 and 200-day averagesPatternshover a marker to name it
57.3% under the 52-week high of 3.44 on 11 Aug 2026. 52-week low 0.80 on 17 Mar 2026. Last 15 sessions, 119.4% high to low
Volume 0.00× normal · the line is the 50-bar volume average
Setup. RS line 17
CANSLIM 3 of 6 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50%
VCP 4 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 52-Week High/Low: 0-10% below High
Minervini 1 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 1 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 2 of 4 — fails: EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 0 of 4 — fails: P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 2 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 0 of 4 — fails: Institutional Ownership: Over 30%; Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 1 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200
Profile
STIM52-week range, 25% of the way up
0.803.44
Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 2003 and is headquartered in Malvern, PA.
| Employees | 658 |
|---|---|
| IPO | Jun 28, 2018 |
| Beta | 1.35 |
| ATR, 14d | 0.25 |
| Rel volume | 0.00 |
| Short float | 22.61% |
| Insider own | 62.10% |
| Inst own | 28.07% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | $114.28M |
| Enterprise Value | 177.59M |
| Income | -23.08M |
| Sales | 159.76M |
| Book / share | 0.24 |
| Cash / share | 0.36 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 658 |
| IPO | Jun 28, 2018 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 0.72 |
| Price / book | 6.11 |
| Price / cash | 4.07 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | 1.11 |
| Quick Ratio | 1.82 |
| Current Ratio | 2.01 |
| Debt / equity | 4.69 |
| Long-term debt / equity | 4.42 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -0.33 |
|---|---|
| Earnings next year | -0.24 |
| Earnings next quarter | -0.07 |
| Earnings this year | 50.54% |
| Earnings next year | 17.59% |
| Earnings growth, 5 years | 30.48% |
| Past earnings growth | 24.64% 16.51% |
| Past sales growth | 31.76% 24.81% |
| Earnings vs last year | 60.22% |
| Sales vs last year | 23.01% |
| Earnings vs last quarter | 83.63% |
| Sales vs last quarter | 12.51% |
| Earnings | Nov 04 BMO |
| Surprise | 72.34% 2.97% |
Ownership
| Insiders own | 62.10% |
|---|---|
| Insider trades | 1.35% |
| Institutions own | 28.07% |
| Institution trades | -9.84% |
| Return on assets | -16.64% |
| Return on equity | -100.20% |
| Return on capital | -22.76% |
| Gross Margin | 49.47% |
| Operating margin | -9.39% |
| Profit Margin | -14.45% |
| 20-day average | -29.52% |
| 50-day average | -37.42% |
| 200-day average | -21.40% |
Technical
| Shares out | 77.73M |
|---|---|
| Shares floating | 29.46M |
| Short / float | 22.61% |
| Short ratio | 4.59 |
| Short interest | 6.66M |
| 52-week high | 3.44 -57.3% |
| 52-week low | 0.80 +83.7% |
| Volatility | 18.02% 11.07% |
| Average range | 0.25 |
| Strength index | 33.54 |
| Market sensitivity | 1.35 |
| Relative volume | 0.00 |
| Avg Volume | 1.45M |
| Volume | 343 |
Performance
| Perf Week | -31.61% |
|---|---|
| Perf Month | -24.60% |
| Perf Quarter | -55.04% |
| Perf Half Y | 14.87% |
| Perf YTD | 6.54% |
| Perf Year | -27.93% |
| Perf 3Y | 17.62% |
| Perf 5Y | -71.34% |
| Perf 10Y | - |
| Recommendation | 1.00 |
| Target Price | 6.00 |
| Prev Close | 1.43 |
| Price | 1.47 |
| Change % | 2.82% |
Analyst ratings
latest 8 of 8| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Sep 11, 2026 | Initiated | B. Riley Securities | Buy | $5 | +240.1% |
| Jul 20, 2026 | Initiated | BTIG Research | Buy | $5 | +240.1% |
| Aug 13, 2024 | Downgrade | William Blair | Outperform → Mkt Perform | ||
| Oct 13, 2021 | Downgrade | William Blair | Outperform → Mkt Perform | ||
| Oct 13, 2021 | Downgrade | BTIG Research | Buy → Neutral | ||
| Jan 22, 2021 | Upgrade | William Blair | Mkt Perform → Outperform | ||
| Feb 06, 2020 | Initiated | BTIG Research | Buy | $11 | +648.1% |
| Jul 24, 2018 | Initiated | Canaccord Genuity | Buy |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| BWAY | Brainsway Ltd ADR | 402.50M |
| ECOR | ElectroCore Inc | 48.81M |
| MOBI | Mobia Medical Inc | 443.59M |
| NPCE | NeuroPace Inc | 236.50M |
| LIVN | LivaNova PLC | 4.97B |
| CLPT | ClearPoint Neuro Inc | 272.14M |
| NXL | Nexalin Technology Inc | 1.71M |
| CMPS | Compass Pathways Plc ADR | 1.31B |
| LFST | LifeStance Health Group Inc | 5.38B |
| ACHC | Acadia Healthcare Company Inc | 3.52B |
Insider trading
latest 14 of 38| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Anderson Cory | Officer | Nov 10 '26 | Proposed Sale | 2.07 | 5,137 | 10,655 | Nov 10 03:36 PM | |
| Chernett Jorey | 10% Owner | Oct 30 '26 | Buy | 2.27 | 18,000 | 40,860 | 10,620,988 | Nov 02 08:49 AM |
| MACAN WILLIAM ANDREW | Former Officer | Aug 19 '26 | Proposed Sale | 3.10 | 149,891 | 463,934 | Aug 19 02:13 PM | |
| MACAN WILLIAM ANDREW | Officer | Aug 18 '26 | Proposed Sale | 3.21 | 121,033 | 388,274 | Aug 18 04:46 PM | |
| Chernett Jorey | 10% Owner | Aug 14 '26 | Buy | 3.16 | 14,000 | 44,240 | 10,602,988 | Aug 17 10:13 AM |
| Chernett Jorey | 10% Owner | Jul 14 '26 | Buy | 1.78 | 35,000 | 62,300 | 10,588,988 | Jul 15 09:33 AM |
| Sullivan Keith J | Former Officer and Director | Jun 08 '26 | Proposed Sale | 1.29 | 42,164 | 54,345 | Jun 08 04:38 PM | |
| Chernett Jorey | 10% Owner | May 19 '26 | Buy | 1.17 | 100,000 | 117,000 | 10,553,988 | May 20 12:39 PM |
| Chernett Jorey | 10% Owner | May 12 '26 | Buy | 1.34 | 475,000 | 636,500 | 10,453,988 | May 13 08:31 AM |
| Chernett Jorey | 10% Owner | Apr 20 '26 | Buy | 1.58 | 100,000 | 158,000 | 9,878,988 | Apr 22 09:39 AM |
| Chernett Jorey | 10% Owner | Apr 21 '26 | Buy | 1.51 | 100,000 | 151,000 | 9,978,988 | Apr 22 09:39 AM |
| Chernett Jorey | 10% Owner | Mar 30 '26 | Buy | 1.25 | 385,442 | 481,802 | 9,778,988 | Mar 30 07:41 PM |
| Chernett Jorey | 10% Owner | Mar 27 '26 | Buy | 1.35 | 500,000 | 675,000 | 9,393,276 | Mar 30 09:37 AM |
| Chernett Jorey | 10% Owner | Mar 25 '26 | Buy | 1.40 | 125,000 | 175,000 | 8,868,276 | Mar 27 09:33 AM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| PSIL | AdvisorShares Psychedelics ETF | AUM: 43.49M |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| BUSM | EA Bridgeway Ultra-Small Company Market ETF | AUM: 112.81M |
| IWC | iShares Micro-Cap ETF | AUM: 1.23B |
| QQQS | Invesco NASDAQ Future Gen 200 ETF | AUM: 20.78M |
News
latest 14 of 200- Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock (GlobeNewswire) -7.80% -19.40%
- Neuronetics stock tumbles 10% on stock offering launch (Investing.com)
- Neuronetics Announces Proposed Public Offering of Common Stock (GlobeNewswire)
- Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +19.69% -10.17%
- Neuronetics Posts First GAAP Operating Profit And Raises Margin Outlook, But A Held Revenue Guide And Thin Cash Keep The Turnaround On Probation (Earnings Whispers)
- Neuronetics Reports 12.5% Revenue Growth to $42 Million in Q3 2026 as Losses Narrow (InvestorsHub)
- Neuronetics: Q3 Earnings Snapshot (Associated Press)
- Neuronetics Reports Third Quarter 2026 Financial and Operating Results (GlobeNewswire)
- Neuronetics Must Prove Its Profit Pivot Holds As Neurostar Revenue Turns Choppier (Earnings Whispers)
- Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call (GlobeNewswire)
- NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System (GlobeNewswire)
- Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ... (GuruFocus.com) +47.00%
- Neuronetics Narrows Q2 Loss as Greenbrook Growth Drives 9% Revenue Increase (InvestorsHub)
- Neuronetics: Q2 Earnings Snapshot (Associated Press)
Quarterly earnings
2026Q3 EPS -0.020 beat -0.072, from -0.130 a year earlier. Sales 41.96 beat 40.75, from 37.30 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-04 08:30 | -0.020 | -0.072 | -0.020 | 41.96 | 40.75 | EPS -72.3% · sales +3.0% | vs 2025Q3, year-ago quarter · EPS -84.6% · sales +12.5% | 4 | Open +22.57% vs SPY +1.15%. Close +19.69% vs SPY +1.65% |
| 2026Q2ended 2026-06-30 | 2026-08-11 08:30 | -0.050 | -0.123 | -0.047 | 41.57 | 40.17 | EPS -59.3% · sales +3.5% | vs 2025Q2, year-ago quarter · EPS -66.7% · sales +9.1% | 4 | Open +26.04% vs SPY +0.19%. Close +47.00% vs SPY -0.32% |
| 2026Q1ended 2026-03-31 | 2026-05-05 08:30 | -0.160 | -0.174 | -0.155 | 34.45 | 34.17 | EPS -8.2% · sales +0.8% | vs 2025Q1, year-ago quarter · EPS -23.8% · sales +7.8% | 3 | Open +2.48% vs SPY +0.52%. Close +7.43% vs SPY +0.80% |
| 2025Q4ended 2025-12-31 | 2026-03-17 08:30 | -0.100 | -0.106 | -0.104 | 41.78 | 40.67 | EPS -5.2% · sales +2.7% | vs 2024Q4, year-ago quarter · EPS -69.7% · sales +85.7% | 3 | Open -10.66% vs SPY +0.50%. Close -9.93% vs SPY +0.26% |
| 2025Q3ended 2025-09-30 | 2025-11-04 08:30 | -0.130 | -0.125 | -0.134 | 37.30 | 37.81 | EPS +4.2% · sales -1.4% | vs 2024Q3, year-ago quarter · EPS -70.5% · sales +101.3% | 3 | Open -14.08% vs SPY -1.06%. Close +3.61% vs SPY -1.19% |
| 2025Q2ended 2025-06-30 | 2025-08-05 08:30 | -0.150 | -0.078 | -0.153 | 38.11 | 36.78 | EPS +91.6% · sales +3.6% | vs 2024Q2, year-ago quarter · EPS -54.5% · sales +131.7% | 3 | Open -11.80% vs SPY +0.10%. Close -2.47% vs SPY -0.51% |
| 2025Q1ended 2025-03-31 | 2025-05-06 08:30 | -0.210 | -0.124 | -0.206 | 31.98 | 29.07 | EPS +69.6% · sales +10.0% | vs 2024Q1, year-ago quarter · EPS -22.2% · sales +83.6% | 4 | Open -18.44% vs SPY -0.99%. Close 0.00% vs SPY -0.84% |
| 2024Q4ended 2024-12-31 | 2025-03-04 08:30 | -0.330 | -0.243 | -0.332 | 22.49 | 19.63 | EPS +36.1% · sales +14.6% | vs 2023Q4, year-ago quarter · EPS +73.7% · sales +10.7% | 4 | Open +2.11% vs SPY -0.70%. Close +18.78% vs SPY -1.18% |
| 2024Q3ended 2024-09-30 | 2024-11-12 08:30 | -0.440 | -0.229 | -0.441 | 18.53 | 19.14 | EPS +92.1% · sales -3.2% | vs 2023Q3, year-ago quarter · EPS +33.3% · sales +3.6% | 4 | Open -30.00% vs SPY -0.01%. Close -37.27% vs SPY -0.31% |
| 2024Q2ended 2024-06-30 | 2024-08-12 08:30 | -0.330 | -0.269 | -0.327 | 16.45 | 18.65 | EPS +22.6% · sales -11.8% | vs 2023Q2, year-ago quarter · EPS +94.1% · sales -6.6% | 4 | Open -29.78% vs SPY +0.23%. Close -58.15% vs SPY +0.05% |
| 2024Q1ended 2024-03-31 | 2024-05-07 08:30 | -0.270 | -0.310 | -0.267 | 17.42 | 17.12 | EPS -12.8% · sales +1.7% | vs 2023Q1, year-ago quarter · EPS -28.9% · sales +12.1% | 4 | Open -4.27% vs SPY +0.19%. Close -30.67% vs SPY +0.11% |
| 2023Q4ended 2023-12-31 | 2024-03-05 08:30 | -0.190 | -0.259 | -0.185 | 20.31 | 19.85 | EPS -26.8% · sales +2.3% | vs 2022Q4, year-ago quarter · EPS -36.7% · sales +11.6% | 4 | Open +7.53% vs SPY -0.40%. Close +15.41% vs SPY -1.00% |
| 2023Q3ended 2023-09-30 | 2023-11-07 08:30 | -0.330 | -0.310 | -0.325 | 17.88 | 17.58 | EPS +6.5% · sales +1.7% | vs 2022Q3, year-ago quarter · EPS +17.9% · sales +8.4% | 4 | - |
| 2023Q2ended 2023-06-30 | 2023-08-08 08:30 | -0.170 | -0.348 | -0.171 | 17.61 | 17.36 | EPS -51.1% · sales +1.4% | vs 2022Q2, year-ago quarter · EPS -56.4% · sales +7.8% | 4 | - |
| 2023Q1ended 2023-03-31 | 2023-05-09 08:30 | -0.380 | -0.388 | -0.375 | 15.54 | 15.18 | EPS -1.9% · sales +2.4% | vs 2022Q1, year-ago quarter · EPS -7.3% · sales +9.6% | 4 | - |
| 2022Q4ended 2022-12-31 | 2023-03-07 08:30 | -0.300 | -0.380 | -0.305 | 18.20 | 16.82 | EPS -21.0% · sales +8.2% | vs 2021Q4, year-ago quarter · EPS +3.4% · sales +21.1% | 4 | - |
Annual earnings
2025FY EPS -0.590 beat -0.595, from -1.370 a year earlier. Sales 149.16 beat 148.09, from 74.89 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2030FYestimate | - | -0.095 | - | - | 229.05 | - |
| 2029FYestimate | - | -0.140 | - | - | 210.9 | - |
| 2028FYestimate | - | -0.198 | - | - | 192.37 | - |
| 2027FYestimate | - | -0.241 | - | - | 176.95 | - |
| 2026FYestimate | - | -0.292 | - | - | 162.3 | - |
| 2025FY | -0.590 | -0.595 | -0.590 | 149.16 | 148.09 | - |
| 2024FY | -1.370 | -1.270 | -1.377 | 74.89 | 72.03 | - |
| 2023FY | -1.050 | -1.130 | -1.053 | 71.35 | 70.89 | - |
| 2022FY | -1.380 | -1.456 | -1.381 | 65.21 | 63.82 | - |
| 2021FY | -1.220 | -1.238 | -1.224 | 55.31 | 54.37 | - |
| 2020FY | -1.460 | -1.506 | -1.458 | 49.24 | 48.07 | - |
| 2019FY | -1.580 | -1.614 | -1.580 | 62.66 | 62.24 | - |
| 2018FY | -2.690 | -8.192 | -2.693 | 52.78 | 52.03 | - |
Quarterly results
2026Q3 revenue 41.96, from 37.30 a year earlier. Operating margin 1.3%, from -19.6% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026FY E -0.29 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026FY | E | per share | 2026-11-04 | -0.29 | -14.4% |
| 2026Q4 | E | per share | 2026-11-04 | -0.07 | +8.9% |
| 2026FY | R | per share | 2026-11-04 | -0.29 | -19.7% |
| 2026Q4 | R | per share | 2026-11-04 | -0.08 | +15.4% |
| 2026Q4 | S | per share | 2026-11-04 | 44.30 | -1.9% |
| 2026FY | S | - | 2026-11-04 | 162.3 | +0.2% |
| 2026Q3 | R | per share | 2026-10-28 | -0.10 | -1.8% |
| 2026Q3 | E | per share | 2026-10-25 | -0.09 | 0.0% |
| 2026Q3 | S | per share | 2026-10-25 | 40.43 | 0.0% |
| 2026Q2 | R | per share | 2026-07-26 | -0.13 | 0.0% |
| 2026Q2 | E | per share | 2026-07-25 | -0.12 | 0.0% |
| 2026Q2 | S | per share | 2026-07-25 | 40.17 | 0.0% |
| 2026Q1 | S | per share | 2026-04-06 | 34.17 | 0.0% |
| 2026Q1 | E | per share | 2026-03-17 | -0.17 | +34.7% |
| 2026Q1 | R | per share | 2026-03-17 | -0.19 | +46.2% |
| 2025Q4 | S | per share | 2026-02-09 | 40.67 | +0.0% |
| 2025FY | S | - | 2026-02-09 | 148.09 | +0.0% |
| 2025FY | E | per share | 2026-01-18 | -0.59 | 0.0% |
| 2025Q4 | E | per share | 2026-01-18 | -0.11 | 0.0% |
| 2025FY | R | per share | 2026-01-18 | -0.58 | 0.0% |
| 2025Q4 | R | per share | 2025-11-04 | -0.10 | 0.0% |
| 2025Q3 | E | per share | 2025-10-19 | -0.13 | 0.0% |
| 2025Q3 | R | per share | 2025-10-19 | -0.14 | 0.0% |
| 2025Q3 | S | per share | 2025-10-19 | 37.86 | 0.0% |
| 2025Q2 | E | per share | 2025-07-20 | -0.08 | 0.0% |
| 2025Q2 | R | per share | 2025-07-20 | -0.07 | 0.0% |
| 2025Q2 | S | per share | 2025-07-20 | 36.78 | 0.0% |
| 2025Q1 | R | per share | 2025-04-30 | -0.13 | 0.0% |
| 2025Q1 | S | per share | 2025-04-16 | 29.07 | 0.0% |
| 2024FY | E | per share | 2025-03-04 | -1.26 | -0.8% |
| 2024Q4 | E | per share | 2025-03-04 | -0.23 | -5.2% |
| 2025Q1 | E | per share | 2025-03-04 | -0.12 | -34.8% |
| 2024FY | S | per share | 2025-03-04 | 74.20 | +3.0% |
| 2024Q4 | S | per share | 2025-03-04 | 21.80 | +11.0% |
| 2024FY | R | per share | 2025-01-26 | -1.26 | 0.0% |
| 2024Q4 | R | per share | 2025-01-26 | -0.23 | 0.0% |
| 2024Q3 | E | per share | 2024-11-03 | -0.23 | 0.0% |
| 2024Q3 | R | per share | 2024-10-26 | -0.23 | 0.0% |
| 2024Q3 | S | per share | 2024-10-26 | 19.14 | 0.0% |
| 2024Q2 | E | per share | 2024-07-21 | -0.27 | 0.0% |
| 2024Q2 | R | per share | 2024-07-21 | -0.27 | 0.0% |
| 2024Q2 | S | per share | 2024-07-21 | 18.65 | 0.0% |
| 2024Q1 | S | per share | 2024-03-22 | 17.12 | 0.0% |
| 2024Q1 | E | per share | 2024-03-05 | -0.31 | +5.6% |
| 2024Q1 | R | per share | 2024-03-05 | -0.32 | 0.0% |
| 2023FY | E | per share | 2024-01-21 | -1.13 | 0.0% |
| 2023FY | S | per share | 2024-01-21 | 70.89 | 0.0% |
| 2023FY | R | per share | 2024-01-19 | -1.12 | -1.8% |
Estimate history
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.914 | -2.693 | -1.58 | -1.458 | -1.224 | -1.381 | -1.053 | -1.377 | -0.591 | -0.3282 | - |
| Sales USD millions | 40 | 53 | 63 | 49 | 55 | 65 | 71 | 75 | 149 | 160 | - |
| Shares million shares | 18 | 18 | 19 | 19 | 26 | 27 | 29 | 56 | 69 | - | 78 |
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.441 | -0.332 | -0.206 | -0.153 | -0.134 | -0.104 | -0.155 | -0.047 | -0.022 |
| Sales USD millions | 19 | 22 | 32 | 38 | 37 | 42 | 34 | 42 | 42 |
| Shares million shares | 30 | 56 | 66 | 66 | 68 | 69 | 70 | 76 | 78 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 159.76 | 149.16+99.2% | 74.89+5.0% | 71.35+9.4% | 65.21+17.9% | 55.31+12.3% | 49.24-21.4% | 62.66+18.7% | 52.78 |
| Cost of Goods Sold Incl. D&A | 80.73 | 78.35+243.6% | 22.80+5.3% | 21.65+26.4% | 17.13+34.8% | 12.71+1.8% | 12.49-18.8% | 15.39+23.6% | 12.45 |
| Gross Profit | 79.03 | 70.81+35.9% | 52.09+4.8% | 49.70+3.4% | 48.08+12.9% | 42.60+15.9% | 36.75-22.3% | 47.27+17.2% | 40.33 |
| Selling, General and Administrative Excl. Other | 94.02 | 102.24+18.0% | 86.65+8.0% | 80.25-2.2% | 82.09+19.7% | 68.56+16.1% | 59.06-20.4% | 74.20+23.3% | 60.16 |
| Research and Development | 5.56 | 6.58-48.5% | 12.77+34.1% | 9.52+1.9% | 9.34+17.9% | 7.92-13.9% | 9.20-33.1% | 13.75+67.1% | 8.23 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -15.00 | -31.44 | -34.56 | -30.55 | -34.01 | -25.96 | -22.31 | -26.93 | -19.83 |
| Interest Expense | 8.85 | 8.41+15.4% | 7.29+34.5% | 5.42+27.5% | 4.25+5.7% | 4.02-11.1% | 4.52+22.5% | 3.690.0% | 3.69 |
| Unusual Expense | 0.54 | 0.00-100.0% | 4.43 | 0.00-100.0% | 1.10-31.3% | 1.60+73.9% | 0.92 | - | 1.40 |
| Net Income Before Taxes | -23.01 | -39.13 | -43.73 | -30.19 | -37.16 | -31.19 | -27.45 | -29.04 | -24.10 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -23.01 | -39.13 | -43.73 | -30.19 | -37.16 | -31.19 | -27.45 | -29.04 | -24.10 |
| Net Income From Continuing Operations | -23.08 | -39.00 | -43.71 | -30.19 | -37.16 | -31.19 | -27.45 | -29.04 | -24.10 |
| Net Income | -23.08 | -39.00 | -43.71 | -30.19 | -37.16 | -31.19 | -27.45 | -29.04 | -24.10 |
| EPS (Recurring) per share | -0.29 | -0.59 | -1.28 | -1.05 | -1.35 | -1.18 | -1.42 | -1.58 | -2.58 |
| EPS (Basic, Before Extraordinaries) per share | -0.33 | -0.59 | -1.38 | -1.05 | -1.38 | -1.22 | -1.46 | -1.58 | -2.69 |
| EPS (Diluted) per share | -0.33 | -0.59 | -1.38 | -1.05 | -1.38 | -1.22 | -1.46 | -1.58 | -2.69 |
| EBITDA | -12.02 | -27.97 | -32.49 | -28.55 | -32.36 | -24.90 | -21.37 | -25.86 | -18.95 |
| Non-Operating Income (Expense) | 1.38 | 0.72-71.8% | 2.55-56.0% | 5.79+163.2% | 2.20+464.1% | 0.39+30.0% | 0.30-80.9% | 1.57+91.5% | 0.82 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 4.72 | 6.85+22.3% | 5.60-23.5% | 7.32-16.3% | 8.75+11.2% | 7.87+78.9% | 4.40+28.3% | 3.43+97.1% | 1.74 |
| Price To Sales Ratio ratio | 1.13 | 0.61 | 0.68 | 1.16 | 2.83 | 2.05 | 4.25 | 1.32 | 3.28 |
| Gross Margin % | 49.47 | 47.47 | 69.55 | 69.66 | 73.73 | 77.02 | 74.63 | 75.44 | 76.42 |
| Operating Margin % | -9.39 | -21.08 | -46.15 | -42.82 | -52.16 | -46.94 | -45.30 | -42.98 | -37.58 |
| Net Margin % | -14.45 | -26.15 | -58.36 | -42.31 | -56.99 | -56.39 | -55.75 | -46.35 | -45.66 |
| Shares Outstanding million shares | 77.73 | 68.99+23.9% | 55.68+91.4% | 29.09+6.7% | 27.27+3.3% | 26.39+38.1% | 19.11+2.5% | 18.64+5.1% | 17.74 |
| Market Capitalization | 111.15 | 111.15+115.3% | 51.63-38.5% | 83.91-55.1% | 187.01+59.0% | 117.60-44.2% | 210.82+152.0% | 83.66-75.4% | 340.15 |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 41.96+12.5% | 41.57+9.1% | 34.45+7.7% | 41.78+85.8% | 37.30+101.3% | 38.11+131.7% | 31.98+83.6% | 22.49+10.7% |
| Cost of Goods Sold Incl. D&A | 20.47-2.8% | 20.75-2.4% | 19.05+11.1% | 20.47+154.6% | 21.07+318.1% | 21.25+340.0% | 17.15+250.7% | 8.04+59.2% |
| Gross Profit | 21.49+32.5% | 20.82+23.5% | 15.41+3.9% | 21.30+47.4% | 16.22+20.2% | 16.86+45.1% | 14.83+18.4% | 14.45-5.4% |
| Selling, General and Administrative Excl. Other | 20.95-11.0% | 22.32-10.4% | 24.40-5.6% | 26.35+3.7% | 23.54+10.9% | 24.91+23.7% | 25.84+33.3% | 25.40+28.9% |
| Research and Development | 1.19-20.7% | 1.34-25.6% | 1.36-16.0% | 1.67-71.1% | 1.50-38.0% | 1.80-19.3% | 1.62-31.1% | 5.77+161.1% |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 0.54 | -1.50 | -8.99 | -5.04 | -7.32 | -8.06 | -11.01 | -10.95 |
| Interest Expense | 2.14-3.2% | 2.12+7.6% | 2.27+18.2% | 2.32+31.8% | 2.21+27.7% | 1.97-0.5% | 1.92+4.9% | 1.76-4.3% |
| Unusual Expense | 0.00 | 0.00 | 0.54 | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00 |
| Net Income Before Taxes | -1.56 | -3.46 | -10.78 | -7.21 | -9.40 | -9.84 | -12.69 | -12.16 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -1.56 | -3.46 | -10.78 | -7.21 | -9.40 | -9.84 | -12.69 | -12.16 |
| Net Income From Continuing Operations | -1.69 | -3.44 | -10.79 | -7.16 | -9.04 | -10.12 | -12.68 | -12.16 |
| Net Income | -1.69 | -3.44 | -10.79 | -7.16 | -9.04 | -10.12 | -12.68 | -12.16 |
| EPS (Recurring) per share | -0.02 | -0.05 | -0.15 | -0.10 | -0.13 | -0.15 | -0.21 | -0.33 |
| EPS (Basic, Before Extraordinaries) per share | -0.02 | -0.05 | -0.15 | -0.10 | -0.13 | -0.15 | -0.21 | -0.33 |
| EPS (Diluted) per share | -0.02 | -0.05 | -0.15 | -0.10 | -0.13 | -0.15 | -0.21 | -0.33 |
| EBITDA | 1.28 | -0.77 | -8.25 | -4.28 | -6.43 | -7.16 | -10.10 | -10.51 |
| Non-Operating Income (Expense) | 0.05-61.5% | 0.16-15.8% | 1.02+308.0% | 0.15-72.7% | 0.13-75.9% | 0.19-70.8% | 0.25-69.1% | 0.55-38.2% |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 0.18-87.2% | 0.69-61.9% | 1.68+16.7% | 2.18+70.3% | 1.41-0.7% | 1.81+16.0% | 1.44+7.5% | 1.28-21.5% |
| Price To Sales Ratio ratio | 1.13 | 0.61 | 0.67 | 0.64 | 1.41 | 2.08 | 2.53 | 0.79 |
| Gross Margin % | 51.21 | 50.09 | 44.72 | 50.99 | 43.49 | 44.23 | 46.37 | 64.25 |
| Operating Margin % | 1.29 | -3.61 | -26.11 | -12.07 | -19.63 | -21.15 | -34.45 | -48.68 |
| Net Margin % | -4.03 | -8.27 | -31.32 | -17.13 | -24.25 | -26.56 | -39.64 | -54.05 |
| Shares Outstanding million shares | 77.73+13.6% | 76.19+15.2% | 69.58+5.7% | 68.99+23.9% | 68.44+125.7% | 66.11+119.3% | 65.82+119.5% | 55.68+91.4% |
| Market Capitalization | 111.15-38.4% | 90.46-60.6% | 100.45-58.5% | 94.51+83.1% | 180.52+684.2% | 229.71+325.4% | 242.20+71.0% | 51.63-38.5% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 | 2017FY12/31/2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 34.13+73.6% | 19.66-67.5% | 60.58-15.7% | 71.88-25.4% | 96.34+89.5% | 50.84-33.6% | 76.59-26.8% | 104.58+258.8% | 29.15 |
| Short Term Receivables | 17.12-29.5% | 24.29+36.2% | 17.84+29.1% | 13.82+77.6% | 7.78+8.5% | 7.17+9.1% | 6.57+16.9% | 5.62+31.6% | 4.27 |
| Inventories | 4.33+1.9% | 4.25-47.5% | 8.09-9.1% | 8.90+35.7% | 6.56+76.3% | 3.72+34.3% | 2.77+14.0% | 2.43-1.6% | 2.47 |
| Other Current Assets | 5.97-39.8% | 9.92+36.3% | 7.28+74.6% | 4.17-10.3% | 4.65+41.8% | 3.28+30.2% | 2.52+37.0% | 1.84+64.3% | 1.12 |
| Total Current Assets | 61.55+5.9% | 58.12-38.0% | 93.79-5.0% | 98.77-14.4% | 115.33+77.4% | 65.01-26.5% | 88.45-22.7% | 114.47+209.3% | 37.01 |
| Net Property, Plant & Equipment | 28.03-15.9% | 33.34+597.5% | 4.78-10.2% | 5.32+4.3% | 5.10+22.9% | 4.15-15.3% | 4.90+105.9% | 2.38+75.0% | 1.36 |
| Total Investments and Advances | 0.10+11.1% | 0.09-86.4% | 0.66-45.9% | 1.22-28.2% | 1.70-27.0% | 2.33+34.7% | 1.73 | 0.00 | 0.00 |
| Long-Term Note Receivable | 0.15-48.3% | 0.29-92.3% | 3.79+952.8% | 0.36-96.4% | 10.11 | - | - | - | - |
| Intangible Assets | 41.77+9.2% | 38.24 | - | 0.00 | 0.00 | 0.00 | 0.00 | - | - |
| Other Assets | 9.95-8.0% | 10.82-15.5% | 12.80+14.2% | 11.21+24.8% | 8.98+25.2% | 7.17+41.1% | 5.08+2888.2% | 0.17-70.2% | 0.57 |
| Total Assets | 141.55+0.5% | 140.90+21.6% | 115.83-0.9% | 116.88-17.2% | 141.22+79.5% | 78.66-21.5% | 100.17-14.4% | 117.02+200.5% | 38.94 |
| Short Term Debt Incl. Current Port. of LT Debt | 5.56+16.1% | 4.79+470.2% | 0.84-94.0% | 13.95+1982.1% | 0.67+13.6% | 0.59-95.0% | 11.81 | 0.00 | 0.00 |
| Accounts Payable | 10.74-3.1% | 11.08+133.3% | 4.75+95.5% | 2.43-43.5% | 4.30+14.7% | 3.75-18.8% | 4.62+22.9% | 3.76+49.8% | 2.51 |
| Income Tax Payable | - | - | - | - | - | - | - | - | 0.32 |
| Other Current Liabilities | 14.22-7.7% | 15.40+8.4% | 14.21-15.5% | 16.82+56.8% | 10.73+14.9% | 9.34-17.1% | 11.26+14.9% | 9.80+7.0% | 9.16 |
| Total Current Liabilities | 30.52-2.4% | 31.27+57.8% | 19.81-40.3% | 33.20+111.5% | 15.70+14.8% | 13.68-50.6% | 27.69+104.2% | 13.56+13.1% | 11.99 |
| Long Term Debt | 84.74+8.9% | 77.84+26.3% | 61.63+138.9% | 25.80-33.6% | 38.87+3.0% | 37.74+67.6% | 22.52-25.9% | 30.39+2.8% | 29.56 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.05 | 0.00-100.0% | 0.20-75.9% | 0.83-43.5% | 1.47-15.5% | 1.74-17.5% | 2.11+3.9% | 2.03-30.0% | 2.90 |
| Total Liabilities | 115.31+5.7% | 109.10+33.6% | 81.64+36.5% | 59.82+6.7% | 56.05+5.4% | 53.16+1.6% | 52.32+13.8% | 45.98+3.4% | 44.45 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 187.14 |
| Common Equity | 22.38-19.2% | 27.71-19.0% | 34.19-40.1% | 57.06-33.0% | 85.17+234.1% | 25.49-46.7% | 47.85-32.6% | 71.04 | -192.65 |
| Total Shareholders Equity | 22.38-19.2% | 27.71-19.0% | 34.19-40.1% | 57.06-33.0% | 85.17+234.1% | 25.49-46.7% | 47.85-32.6% | 71.04 | -5.52 |
| Accumulated Minority Interest | 3.86-5.6% | 4.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 26.24-17.5% | 31.80-7.0% | 34.19-40.1% | 57.06-33.0% | 85.17+234.1% | 25.49-46.7% | 47.85-32.6% | 71.04 | -5.52 |
| Total Liabilities & Stockholders Equity | 141.55+0.5% | 140.90+21.6% | 115.83-0.9% | 116.88-17.2% | 141.22+79.5% | 78.66-21.5% | 100.17-14.4% | 117.02+200.5% | 38.94 |
| Book Value Per Share per share | 0.32-36.0% | 0.50-57.6% | 1.18-43.5% | 2.09-35.3% | 3.23+142.9% | 1.33-48.2% | 2.57-35.8% | 4.00 | -10.96 |
| Tangible Book Value Per Share per share | -0.28 | -0.19-116.1% | 1.18-43.5% | 2.09-35.3% | 3.23+142.9% | 1.33-48.2% | 2.57-35.8% | 4.00 | -10.96 |
| Full-Time Employees people | 658-8.1% | 716+252.7% | 203+4.6% | 194+10.9% | 175+38.9% | 126-46.4% | 235+67.9% | 140-3.4% | 145 |
| Price to Book Ratio ratio | 5.94 | 5.20 | 2.21 | 2.95 | 1.38 | 8.33 | 1.75 | 4.83 | 4.37 |
| Return on Assets % | -27.61 | -34.05 | -25.95 | -28.79 | -28.37 | -30.70 | -26.75 | -30.90 | -50.39 |
| Return on Equity % | -155.73 | -141.23 | -66.17 | -52.25 | -56.37 | -74.86 | -48.86 | -73.55 | - |
| Return on Invested Capital % | -36.41 | -41.41 | -31.51 | -44.85 | -25.15 | -43.41 | -41.27 | -23.76 | -66.80 |
| Quick Ratio ratio | 1.87 | 1.72 | 4.33 | 2.71 | 6.93 | 4.48 | 3.09 | 8.26 | 2.88 |
| Current Ratio ratio | 2.02 | 1.86 | 4.73 | 2.98 | 7.34 | 4.75 | 3.19 | 8.44 | 3.09 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -23.01 | -39.13 | -43.73 | -30.19 | -37.16 | -31.19 | -27.45 | -29.04 | -24.10 |
| Depreciation | 2.98 | 3.46+67.1% | 2.07+3.0% | 2.01+21.8% | 1.65+55.7% | 1.06+12.8% | 0.94-11.3% | 1.06+20.5% | 0.88 |
| Other Funds (Non Cash) | 6.79 | 8.72-50.1% | 17.46+70.3% | 10.25+7.3% | 9.55+8.6% | 8.79+37.3% | 6.40+45.1% | 4.41+4.8% | 4.21 |
| Funds from Operations | -13.23 | -26.95 | -24.19 | -17.93 | -25.96 | -21.35 | -20.11 | -23.57 | -19.01 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 4.95 | 6.58 | -6.81 | -14.10 | -4.78 | -6.64 | -8.28 | -6.91 | -1.58 |
| Cash from Operating Activities | -8.28 | -20.37 | -31.00 | -32.04 | -30.74 | -27.98 | -28.39 | -30.48 | -20.59 |
| Capital Expenditures | -1.30 | -0.80 | -1.47 | -2.37 | -3.27 | -2.35 | -0.73 | -0.81 | -1.01 |
| Net Assets From Acquisitions | 0.00 | 0.00 | -2.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Sale of Fixed Assets and Businesses | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -7.49 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00-100.0% | 1.61+53.3% | 1.05-89.5% | 10.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -1.27 | -0.80 | -2.41 | -1.32-119.6% | 6.73 | -9.84 | -0.73 | -0.81 | -1.01 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 10.23 | 26.82+964.3% | 2.52 | 0.00-100.0% | 0.30-99.6% | 83.01+11930.4% | 0.69-71.5% | 2.42-97.5% | 97.04 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 10.23 | 26.82+964.3% | 2.52 | 0.00-100.0% | 0.30-99.6% | 83.01+11930.4% | 0.69-71.5% | 2.42-97.5% | 97.04 |
| Proceedsfrom Stock Options | 8.03 | 26.81 | 0.00 | 0.00 | 0.00-100.0% | 80.57 | 0.00 | 0.00-100.0% | 96.53 |
| Issuance or Reduction of Debt, Net | -5.30 | 9.62 | -5.14-122.6% | 22.70 | 0.00 | 0.00-100.0% | 1.68 | 0.00 | 0.00 |
| Change in Long Term Debt | -5.30 | 9.62 | -5.14-122.6% | 22.70 | 0.00 | 0.00-100.0% | 1.68 | 0.00 | 0.00 |
| Issuance of Long Term Debt | -0.09 | 9.83-82.1% | 54.85+129.5% | 23.90 | 0.00 | 0.00-100.0% | 40.54 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -5.21 | -0.21 | -60.00 | -1.20 | 0.00 | 0.00 | -38.86 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | -1.94 | -0.59 | -4.18 | 0.00 | -0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | -1.94 | -0.59 | -4.18 | 0.00 | -0.09 | 0.00 | - | 0.00 | 0.00 |
| Cash from Financing Activities | 2.94 | 35.85 | -6.81-130.0% | 22.70+10709.5% | 0.21-99.7% | 83.01+3402.5% | 2.37-2.1% | 2.42-97.5% | 97.04 |
| Net Change in Cash | -6.62 | 14.68 | -40.22 | -10.66 | -23.80-152.7% | 45.18 | -26.75 | -28.88-138.3% | 75.44 |
| Free Cash Flow | -9.58 | -21.18 | -32.46 | -34.41 | -34.01 | -30.34 | -29.12 | -31.30 | -21.60 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 28.11-18.9% | 25.18+42.7% | 19.22-10.3% | 34.13+73.6% | 34.65+61.6% | 17.64-59.3% | 21.43-55.9% | 19.66-67.5% |
| Short Term Receivables | 14.69-23.4% | 16.27-38.9% | 16.21-39.7% | 17.12-29.5% | 19.19-0.6% | 26.64+36.5% | 26.89+37.1% | 24.29+36.2% |
| Inventories | 4.94+14.4% | 5.50+11.3% | 4.71+15.7% | 4.33+1.9% | 4.32-12.9% | 4.94-19.5% | 4.07-39.2% | 4.25-47.5% |
| Other Current Assets | 6.15-8.6% | 6.28-9.1% | 7.03-15.1% | 5.97-39.8% | 6.73-13.3% | 6.91+5.8% | 8.28+18.3% | 9.92+36.3% |
| Total Current Assets | 53.89-17.0% | 53.23-5.2% | 47.17-22.3% | 61.55+5.9% | 64.89+21.4% | 56.14-25.7% | 60.67-25.9% | 58.12-38.0% |
| Net Property, Plant & Equipment | 27.88-4.4% | 27.38-8.1% | 26.94-17.2% | 28.03-15.9% | 29.17+634.8% | 29.80+607.8% | 32.55+628.2% | 33.34+597.5% |
| Total Investments and Advances | 0.090.0% | 0.07-30.0% | 0.11+57.1% | 0.10+11.1% | 0.09-35.7% | 0.10-63.0% | 0.07-86.5% | 0.09-86.4% |
| Intangible Assets | 40.68-1.2% | 41.04+8.1% | 41.41+9.3% | 41.77+9.2% | 41.18 | 37.96 | 37.88 | 38.24 |
| Other Assets | 9.40-5.1% | 9.77-5.2% | 9.71-7.5% | 9.95-8.0% | 9.91-27.5% | 10.31-24.6% | 10.50-21.0% | 10.82-15.5% |
| Total Assets | 131.96-9.3% | 131.53-2.3% | 125.44-11.7% | 141.55+0.5% | 145.47+96.3% | 134.65+39.1% | 141.99+36.8% | 140.90+21.6% |
| Short Term Debt Incl. Current Port. of LT Debt | 5.04-9.7% | 5.14-3.4% | 5.42+10.2% | 5.56+16.1% | 5.58+548.8% | 5.32-63.2% | 4.92+478.8% | 4.79+470.2% |
| Accounts Payable | 9.96-13.9% | 12.42+27.8% | 11.43+34.8% | 10.74-3.1% | 11.57+251.7% | 9.72+137.1% | 8.48+184.6% | 11.08+133.3% |
| Other Current Liabilities | 11.86+0.7% | 10.75-15.8% | 11.43-0.1% | 14.22-7.7% | 11.78-7.5% | 12.76+19.4% | 11.44+7.2% | 15.40+8.4% |
| Total Current Liabilities | 26.86-7.2% | 28.31+1.8% | 28.29+13.9% | 30.52-2.4% | 28.94+71.2% | 27.80-5.0% | 24.84+71.3% | 31.27+57.8% |
| Long Term Debt | 82.69-2.9% | 81.38+8.0% | 79.97+3.0% | 84.74+8.9% | 85.17+78.0% | 75.34+56.5% | 77.62+26.0% | 77.84+26.3% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.01 | 0.20 | 0.13 | 0.05 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% |
| Total Liabilities | 109.56-4.0% | 109.89+6.5% | 108.38+5.8% | 115.31+5.7% | 114.11+76.3% | 103.14+33.2% | 102.46+34.5% | 109.10+33.6% |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 18.71-31.6% | 17.85-34.3% | 13.27-62.6% | 22.38-19.2% | 27.36+191.7% | 27.15+40.0% | 35.45+28.2% | 27.71-19.0% |
| Total Shareholders Equity | 18.71-31.6% | 17.85-34.3% | 13.27-62.6% | 22.38-19.2% | 27.36+191.7% | 27.15+40.0% | 35.45+28.2% | 27.71-19.0% |
| Accumulated Minority Interest | 3.69-7.8% | 3.79-13.1% | 3.79-7.1% | 3.86-5.6% | 4.00 | 4.36 | 4.08 | 4.09 |
| Total Equity | 22.40-28.6% | 21.64-31.3% | 17.06-56.8% | 26.24-17.5% | 31.36+234.3% | 31.51+62.5% | 39.53+42.9% | 31.80-7.0% |
| Total Liabilities & Stockholders Equity | 131.96-9.3% | 131.53-2.3% | 125.44-11.7% | 141.55+0.5% | 145.47+96.3% | 134.65+39.1% | 141.99+36.8% | 140.90+21.6% |
| Book Value Per Share per share | 0.24-40.0% | 0.23-43.9% | 0.19-64.8% | 0.32-36.0% | 0.40+29.0% | 0.41-35.9% | 0.54-41.3% | 0.50-57.6% |
| Tangible Book Value Per Share per share | -0.28 | -0.30 | -0.40 | -0.28 | -0.20-164.5% | -0.16-125.0% | -0.04-104.3% | -0.19-116.1% |
| Full-Time Employees people | - | - | - | 658-8.1% | - | - | - | 716+252.7% |
| Price to Book Ratio ratio | 5.94 | 6.82 | 4.47 | 3.45 | 6.65 | 6.48 | 7.40 | 5.20 |
| Return on Assets % | -16.64 | -22.87 | -27.76 | -27.61 | -40.07 | -41.73 | -39.06 | -33.66 |
| Return on Equity % | -100.20 | -135.26 | -152.36 | -155.73 | -239.53 | -207.57 | -152.14 | -139.60 |
| Return on Invested Capital % | -1.67 | -3.47 | -11.57 | -6.68 | -8.04 | -9.87 | -11.21 | -11.52 |
| Quick Ratio ratio | 1.82 | 1.69 | 1.50 | 1.87 | 2.09 | 1.84 | 2.28 | 1.72 |
| Current Ratio ratio | 2.01 | 1.88 | 1.67 | 2.02 | 2.24 | 2.02 | 2.44 | 1.86 |
Cash flow, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1.56 | -3.46 | -10.78 | -7.21 | -9.40 | -9.84 | -12.69 | -12.68 |
| Depreciation | 0.74-16.9% | 0.73-18.9% | 0.74-18.7% | 0.77+71.1% | 0.89+74.5% | 0.90+60.7% | 0.91+62.5% | 0.45-10.0% |
| Other Funds (Non Cash) | 0.50-75.1% | 1.09-52.8% | 2.44+48.8% | 2.76-52.7% | 2.01-70.9% | 2.31-10.1% | 1.64-23.4% | 5.84+220.9% |
| Funds from Operations | -0.31 | -1.64 | -7.59 | -3.68 | -6.50 | -6.63 | -10.14 | -6.39 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 1.61-71.9% | 0.58-81.4% | -1.83 | 4.59 | 5.72+1044.0% | 3.12+79.3% | -6.85 | -2.21-142.6% |
| Cash from Operating Activities | 1.29 | -1.06 | -9.42 | 0.91 | -0.79 | -3.50 | -16.99 | -8.60-503.8% |
| Capital Expenditures | -0.47 | -0.42 | -0.20 | -0.22 | -0.11 | -0.25 | -0.22 | -0.09 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.55 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 0.27-15.6% |
| Cash from Investing Activities | -0.47 | -0.42 | -0.17 | -0.22 | -0.11-1200.0% | -0.25 | -0.22-414.3% | -2.38 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 2.79-65.0% | 7.58 | 0.00-100.0% | -0.14-123.3% | 7.98+315.6% | 0.00 | 18.98 | 0.60 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 2.79-65.0% | 7.58 | 0.00-100.0% | -0.14-123.3% | 7.98+315.6% | 0.00 | 18.98 | 0.60 |
| Proceedsfrom Stock Options | 0.59-92.6% | 7.58 | 0.00-100.0% | -0.14 | 7.98 | 0.00 | 18.97 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.00-100.0% | 0.00 | -5.00 | -0.30-103.3% | 9.92 | 0.00 | 0.00 | 8.96-59.7% |
| Change in Long Term Debt | 0.00-100.0% | 0.00 | -5.00 | -0.30-103.3% | 9.92 | 0.00 | 0.00 | 8.96-59.7% |
| Issuance of Long Term Debt | 0.00-100.0% | 0.00 | 0.00 | -0.09-101.0% | 9.92-78.4% | 0.00 | 0.00 | 8.96-59.7% |
| Reduction of Long Term Debt | 0.00 | 0.00 | -5.00 | -0.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | -0.65 | -0.12 | -0.58 | -0.59 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | -0.65 | -0.12 | -0.58 | -0.59 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 2.09-88.3% | 7.46 | -5.58-129.4% | -1.03-110.8% | 17.90 | 0.00 | 18.98 | 9.56-57.1% |
| Net Change in Cash | 2.91-82.9% | 5.98 | -15.17-961.9% | -0.34 | 17.00 | -3.75 | 1.76 | -1.41-105.9% |
| Free Cash Flow | 0.82 | -1.48 | -9.62 | 0.69 | -0.90 | -3.76 | -17.21 | -8.69-795.2% |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Product | 70.45 | 62.18 | -11.7% | 41.7% |
| Service | 4.45 | 86.98 | +1856.7% | 58.3% |
| Total | 74.89 | 149.16 | +99.2% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| United States | 74.89 | 149.16 | +99.2% | 100.0% |
| Total | 74.89 | 149.16 | +99.2% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 22.61% | 6.7M | 29.5M | 1.62M |
| 2026-10-15 | 24.97% | 7.2M | 28.9M | 1.99M |
| 2026-09-30 | 24.47% | 7.1M | 28.9M | 2.08M |
| 2026-09-15 | 21.50% | 6.2M | 28.9M | 2.21M |
| 2026-08-31 | 23.09% | 6.7M | 28.9M | 2.14M |
| 2026-08-14 | 27.87% | 8.0M | 28.9M | 2.46M |
| 2026-07-31 | 38.87% | 9.3M | 24.0M | 2.22M |
| 2026-07-15 | 38.21% | 9.4M | 24.5M | 2.02M |
| 2026-06-30 | 31.08% | 7.7M | 24.7M | 2.21M |
| 2026-06-15 | 39.67% | 9.8M | 24.7M | 2.42M |
| 2026-05-29 | 36.41% | 9.9M | 27.1M | 2.35M |
| 2026-05-15 | 35.02% | 9.6M | 27.5M | 2.12M |
| 2026-04-30 | 40.63% | 10.5M | 25.8M | 2.32M |
| 2026-04-15 | 44.06% | 10.9M | 24.8M | 2.23M |
| 2026-03-31 | 26.14% | 9.4M | 35.9M | 2.11M |
| 2026-03-13 | 26.09% | 9.4M | 35.9M | 1.82M |
| 2026-02-27 | 28.93% | 10.3M | 35.5M | 1.85M |
| 2026-02-13 | 23.67% | 8.4M | 35.5M | 2.10M |
| 2026-01-30 | 25.47% | 8.6M | 33.7M | 1.70M |
| 2026-01-15 | 19.76% | 7.2M | 36.2M | 1.67M |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 0.50 | 0.70 | 1.00 | 0.95 | - | 40.00 | 4.00 | 0.943 | -0.010 | 0.000 |
| call | 1.00 | 0.25 | 1.00 | 0.65 | 1241.4% | 235 | 0.00 | 0.802 | -0.021 | 0.001 |
| call | 1.50 | 0.00 | 0.85 | 1.00 | 1158.2% | 184 | 0.00 | 0.735 | -0.040 | 0.001 |
| call | 2.00 | 0.00 | 0.25 | 0.02 | 496.1% | 163 | 14.00 | 0.461 | -0.026 | 0.001 |
| call | 2.50 | 0.00 | 1.00 | 0.10 | 402.4% | 508 | 0.00 | 0.257 | -0.017 | 0.001 |
| call | 5.00 | 0.00 | 0.75 | 0.05 | 643.1% | 2,025 | 0.00 | 0.196 | -0.024 | 0.001 |
| call | 7.50 | 0.00 | 0.80 | 0.10 | 763.2% | 14.00 | 0.00 | 0.178 | -0.027 | 0.001 |
| put | 0.50 | 0.00 | 0.05 | 0.05 | - | 6.00 | 0.00 | -0.069 | -0.021 | 0.000 |
| put | 1.00 | 0.00 | 0.50 | 0.00 | 551.3% | 0.00 | 0.00 | -0.198 | -0.020 | 0.001 |
| put | 1.50 | 0.00 | 1.00 | 0.10 | 191.6% | 191 | 0.00 | -0.265 | -0.040 | 0.001 |
| put | 2.00 | 0.35 | 0.90 | 0.60 | 594.0% | 195 | 30.00 | -0.539 | -0.026 | 0.001 |
| put | 2.50 | 0.55 | 1.25 | 0.90 | 514.1% | 109 | 0.00 | -0.743 | -0.017 | 0.001 |
| put | 5.00 | 2.90 | 3.90 | 2.30 | 963.3% | 1.00 | 0.00 | -0.804 | -0.023 | 0.001 |
| put | 7.50 | 4.80 | 7.90 | 4.45 | 0.0% | 0.00 | 0.00 | -0.822 | -0.026 | 0.001 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-12 | 8-K/A | 2026-11-10 | SEC | |
| 2026-11-12 | 8-K | Current report | 2026-11-10 | SEC |
| 2026-11-12 | 424B5 | SEC | ||
| 2026-11-10 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-11-10 | 424B5 | SEC | ||
| 2026-11-10 | 8-K | Current report | 2026-11-05 | SEC |
| 2026-11-04 | 8-K | Current report | 2026-11-04 | SEC |
| 2026-11-04 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-30 | SEC |
| 2026-08-24 | SCHEDULE 13D/A | SEC | ||
| 2026-08-19 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-18 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-17 | 8-K | Current report | 2026-08-11 | SEC |
| 2026-08-17 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-13 | SEC |
| 2026-08-14 | SCHEDULE 13G | SEC | ||
| 2026-08-11 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans | SEC | |
| 2026-08-11 | 8-K | Current report | 2026-08-11 | SEC |
| 2026-08-11 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-08-04 | SCHEDULE 13D/A | SEC | ||
| 2026-07-23 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-23 | SEC |
| 2026-07-23 | 3 | Initial statement of beneficial ownership of securities | 2026-07-23 | SEC |
| 2026-07-20 | 8-K | Current report | 2026-07-09 | SEC |
| 2026-07-15 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-14 | SEC |
| 2026-07-13 | 3 | Initial statement of beneficial ownership of securities | 2026-07-01 | SEC |
| 2026-06-23 | 8-K | Current report | 2026-06-16 | SEC |
| 2026-06-17 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-15 | SEC |
| 2026-06-17 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-28 | SEC |
| 2026-06-08 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-05-29 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-28 | SEC |
| 2026-05-29 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-28 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 40.86K | 1 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 44.24K | 1 | 0 | 0 |
| 2026-07 | 62.30K | 1 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 753.50K | 2 | 0 | 0 |
| 2026-04 | 309.00K | 2 | 0 | 0 |
| 2026-03 | 3.64M | 8 | 106.31K | 4 |
| 2026-02 | 0 | 0 | 164.10K | 6 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| Madryn Asset Management, LP | 24.33% |
| WEXFORD CAPITAL LP | 2.88% |
| FourWorld Capital Management LLC | 2.51% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.17% |
| Lane Generational LLC | 1.66% |
| HighTower Advisors, LLC | 1.45% |
| MASTERS CAPITAL MANAGEMENT LLC | 1.44% |
| AdvisorShares Investments LLC | 1.21% |
| Ikarian Capital, LLC | 1.01% |
| BlackRock, Inc. | 0.86% |
Funds
| Fund | % owned |
|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 1.52% |
| AdvisorShares Psychedelics ETF | 1.07% |
| VANGUARD EXTENDED MARKET INDEX FUND | 0.61% |
| Fidelity Small Cap Index Fund | 0.53% |
| Fidelity Nasdaq Composite Index Fund | 0.29% |
| Fidelity Extended Market Index Fund | 0.28% |
| VANGUARD RUSSELL 2000 INDEX FUND | 0.27% |
| Goldman Sachs Absolute Return Tracker Fund | 0.15% |
| Ultra-Small Company Market Fund | 0.14% |
| iShares Micro-Cap ETF | 0.13% |
OakChart. STIM. Cached 15 minutes. Terms